Cystic Fibrosis (CF) is a genetic disease characterised by a deficit in epithelial Cl 2 secretion which in the lung leads to airway dehydration and a reduced Airway Surface Liquid (ASL) height. The endogenous lipoxin LXA 4 is a member of the newly identified eicosanoids playing a key role in ending the inflammatory process. Levels of LXA 4 are reported to be decreased in the airways of patients with CF. We have previously shown that in normal human bronchial epithelial cells, LXA 4 produced a rapid and transient increase in intracellular Ca 2+ . We have investigated, the effect of LXA 4 on Cl 2 secretion and the functional consequences on ASL generation in bronchial epithelial cells obtained from CF and non-CF patient biopsies and in bronchial epithelial cell lines. We found that LXA 4 stimulated a rapid intracellular Ca 2+ increase in all of the different CF bronchial epithelial cells tested. In non-CF and CF bronchial epithelia, LXA 4 stimulated whole-cell Cl 2 currents which were inhibited by NPPB (calcium-activated Cl 2 channel inhibitor), BAPTA-AM (chelator of intracellular Ca 2+ ) but not by CFTRinh-172 (CFTR inhibitor). We found, using confocal imaging, that LXA 4 increased the ASL height in non-CF and in CF airway bronchial epithelia. The LXA 4 effect on ASL height was sensitive to bumetanide, an inhibitor of transepithelial Cl 2 secretion. The LXA 4 stimulation of intracellular Ca 2+ , whole-cell Cl 2 currents, conductances and ASL height were inhibited by Boc-2, a specific antagonist of the ALX/FPR2 receptor. Our results provide, for the first time, evidence for a novel role of LXA 4 in the stimulation of intracellular Ca 2+ signalling leading to Ca 2+ -activated Cl 2 secretion and enhanced ASL height in non-CF and CF bronchial epithelia. 
Introduction
Cystic fibrosis is caused by the mutation of the gene coding for the Cystic Fibrosis Transmembrane conductance Regulator (CFTR), a cyclic AMP-dependent Cl 2 channel. The major clinical features of CF are chronic pulmonary disease, exocrine pancreatic insufficiency and male infertility [1, 2] . The lung disease is the main cause of morbidity and mortality in CF. The airway epithelium of patients with CF fails to transport Cl 2 and water, resulting in a reduced ASL height and impaired mucociliary clearance. The hyper-absorption of Na + observed in the CF bronchial epithelium may further exacerbate the dehydration of the ASL. It is generally accepted that the dehydration of the airway lumen favours chronic infection and inflammation leading to progressive destruction of the lung [3] . Identification of agents, particularly natural endogenous biologicals, which stimulate alternative non-CFTR Cl 2 secretory pathways and promote ASL hydration and recovery of optimal ASL height are likely to be of therapeutic benefit in improving mucociliary clearance in patients with CF.
The levels of LXA 4 in the airways have been reported to be decreased in patients with CF [4] . Lipoxins are bioactive lipids derived from omega-6 polyunsaturated fatty acids and play important roles in various biological functions [5] . The endogenous lipoxin A 4 (LXA 4 : 5S,6R,15S-trihydroxy-7,9,13-trans-11-eicosatetraenoic acid) is produced at inflammatory sites from the interaction of lipoxygenase activities of several cell types including leukocytes, platelets and epithelial cells. LXA 4 is one member of the newly identified lipid molecules playing a role in ending/ resolving the inflammatory process by modulating neutrophilic inflammation, clearing apoptotic PMN and inhibiting the production of pro-inflammatory cytokines [6] . The deficit in LXA 4 levels in CF airways could be a contributing factor in chronic airway inflammation which characterises these patients.
Very little is known about the role of LXA 4 in the lung beyond its anti-inflammatory effects. We have previously shown that normal human bronchial epithelial cells are a biological target for LXA 4 . The receptor for LXA 4 (ALX/FPR2) is expressed in the bronchial epithelial cell line 16HBE14o-and LXA 4 stimulates an intracellular Ca 2+ mobilisation in these cells [7] . Intracellular Ca 2+ is a major regulator of Cl 2 transport and the stimulation of epithelial Cl 2 secretion would be of major therapeutic benefit in CF to restore efficient airway clearance. We have investigated the effect of LXA 4 on epithelial Cl 2 secretion and its functional consequences on ASL height using bronchial epithelial cells obtained from CF and non-CF patient biopsies and in a variety of bronchial epithelial cell lines commonly used as models for CF ion transport and immunological studies.
Results

LXA 4 Effects on Intracellular Ca
2+ in Normal and CF Bronchial Epithelial Cells LXA 4 induced a rapid increase of intracellular Ca 2+ in all human airway epithelial cell types tested. These results are summarised in typical records obtained in Nuli-1 and CuFi-3 cell lines (figure 1A) and NHBE and CFBE primary cultures ( Figure 1B ) and on corresponding histograms ( Figure 1C ). There was no significant difference in the maximum increase in calcium induced by LXA 4 (100 nM) between non-CF and CF bronchial epithelial cell lines ( Figure 1A and 1C). However the maximum increase obtained in CF bronchial epithelial primary culture (CFBE) was significantly higher than in non-CF (NHBE) bronchial epithelial primary cultures ( Figure 1B and 1C) . The kinetics of the Ca 2+ responses were markedly different between CF and non-CF cells. In the non-CF bronchial epithelial cells (NHBE primary cultures and Nuli-1 cell line), the intracellular Ca 2+ rise induced by LXA 4 was fast and transient with a recovery to basal values within 2 to 5 min ( Figure 1C ). In contrast, in the CF bronchial epithelial cells (CFBE primary cultures and CuFi cell lines), LXA 4 induced a slower increase in Ca 2+ and a delayed (or absent) recovery toward basal values ( Figure 1C ). Thus the total amount of Ca 2+ mobilised in the cytosol upon LXA 4 exposure was higher in CF cells than in non-CF bronchial epithelial cells.
In order to investigate the origin of the calcium signal induced by LXA 4 , we tested the effect of LXA 4 on intracellular Ca 2+ mobilization in the absence of extracellular Ca 2+ in non-CF and CF airway epithelial cells. The results presented in Figure 1A show that in Nuli-1 cells bathed in an external Ca 2+ -free solution, the response to LXA 4 Figure 1A) .
Role of the ALX/FPR2 Receptor in the Calcium Response to LXA 4 The role of the ALX /FPR2 receptor in the Ca 2+ response to LXA 4 was investigated using the specific inhibitor, Boc-2 ( Figure 2 ). The effect of LXA 4 (100 nM) on intracellular Ca 2+ was completely abolished after treatment with Boc-2 (10 mM) in both NuLi-1 (n = 5) and CuFi-3 (n = 4) cells ( figure 2A and 2B) , we investigated the effect of LXA 4 on ion transport using whole cell patch-clamp recording techniques. The whole-cell current-voltage relationships were obtained from whole-cell patch-clamp recordings in non-CF (NHBE primary culture and Nuli-1 cell line) and CF (CFBE primary culture and CuFi-3 cell line) human bronchial epithelial cells.
As shown from the current-voltage curves ( Figure 3 and 4) and in Table 1 , the whole-cell currents under control conditions were outwardly rectified in non-CF and CF cell lines and in primary airway epithelial cells. The reversal potentials (E rev ) obtained in the cell lines (E rev Nuli-1 = 223.863.2 mV, E rev CuFi-3 = 221. 63.6 mV) and primary cultures (E rev NHBE = 222.463.9 mV and E rev CFBE = 222.461.9 mV) indicate that Cl 2 (E Cl = 239 mV) is the main charge carrier under these conditions (Table 1) .
LXA 4 exposure stimulated the whole-cell currents in non-CF and CF airway epithelial cell lines and in normal and CF primary cultures, in a time-dependent and dose-dependent manner, as illustrated in Figure 3 and Figure 4 , respectively.
Typical whole-cell current-voltage relationship in NHBE and CFBE primary cultures recorded over variable duration of LXA 4 (100 nM) exposure illustrate the time-dependence of the response ( Figure 3A and 3B). The statistical significance of the time dependence of current responses have been investigated in non-CF and CF airway epithelial cell lines and primary cultures as shown in Figure 3C . The maximum stimulatory effect on the inward conductance (for outward flux of Cl 2 from the cell) in non-CF airway epithelial cells (Nuli-1 and NHBE) was obtained after 10 min exposure to LXA 4 and declined thereafter to control levels ( Figure 3C ). In CF airway epithelial cells (CuFi-3 and CFBE), the increased inward conductance induced by LXA 4 was sustained without recovery to basal values over the 15 min period of observation ( Figure 3C ).
The dose dependence of the response to LXA 4 was investigated in the non-CF and CF cell lines. The stimulatory effect of LXA 4 on membrane conductance was found to be dose-dependent as illustrated on the typical whole-cell current-voltage relationship obtained from Nuli-1 and CuFi-3 cell lines upon exposure to different LXA4 concentrations (figure 4A and 4B). In both cell lines, significant responses were observed at concentrations as low as 1 pM and the maximum response achieved at 10 nM LXA 4 ( Figure 4C ).
As reported in Table 1 , the inward and outward conductances were significantly increased by LXA 4 (100 nM, 10 min) without any change in the reversal potential in all cell types studied including primary cultures of CF and non-CF bronchial epithelia and CF and non-CF cell lines.
Role of the ALX/FPR2 Receptor in the Whole Cell Conductance Responses to LXA 4 The inhibitory effect of the Boc-2 antagonist on calcium responses to LXA 4 indicate a role for the ALX/FPR2 receptor in transducing LXA 4 responses in airway epithelial cells. This is also true for lipoxin effects on membrane ionic currents where treatment of Nuli-1 and CuFi-3 cells with Boc-2 (10 mM) completely abolished the stimulatory effect of LXA 4 on the whole-cell current. As indicated in figure 4C , Boc-2 did not affect the basal inward conductance but significantly prevented the increase in inward conductance induced by LXA 4 ( Figure 4C ).
Role of Intracellular Ca
2+ in the Whole-cell Conductance Responses to LXA 4 The role of intracellular Ca 2+ in the LXA 4 induced whole-cell currents was evaluated using BAPTA-AM in the patch pipette as a chelator of intracellular Ca 2+ . Under these conditions of low intracellular Ca 2+ , the basal whole-cell conductances remained unchanged, whereas the lipoxin-stimulated currents were absent in BAPTAM-treated cell. The use of BAPTA-AM demonstrated the absolute requirement for an increase in intracellular calcium levels to transduce the effect of LXA 4 on whole-cell inward conductance in both NuLi-1 cells and in CuFi-3 cells ( Figure 4C ).
LXA 4 Effect on Cl 2 Secretion
The contribution of Cl 2 channels to the LXA 4 induced current, was tested using chloride ion channel inhibitors; NPPB (calciumactivated Cl 2 channel inhibitor) and CFTR-inh172 (CFTR Cl 2 channel inhibitor), and recording their effect on membrane current and conductance responses to LXA 4 in CF and non-CF cells ( Figure 5 ). Pre-treatment of CFBE primary cultured cells for 2 min with NPPB (1 mM) prior to LXA 4 exposure, completely inhibited the stimulatory effect of LXA 4 on whole-cell current (p.0.5, n = 3). Furthermore, the addition of NPPB (1 mM) 10 min after exposure to LXA 4 (100 nM), immediately inhibited the whole-cell currents in non-CF and CF cells. Figure 5A illustrates a typical experiment performed in NHBE primary cells showing the inhibitory effect of NPPB treatment after LXA4 stimulation of the whole cell currents. A summary of the inhibitory effects of NPPB on inward conductance in the CF and non-CF primary cultures, and CF cell line (CuFi-3) are presented in figure 5A . As an additional proof for the role of Cl 2 channels in driving the LXA 4 induced current, we found that in the absence of an electrochemical driving force for chloride ions (equimolar Cl 2 replacement in the bath and patch pipette), LXA 4 did not produce a change in whole-cell current in any of the cell types tested (data not shown).
The specific CFTR inhibitor, CFTR-inh172, had no effect of CFTR-inh172 on basal or LXA 4 -stimulated membrane current and conductance in CFBE and CuFi-3 cells (data not shown), consistent with the absence of functional CFTR. Moreover, the CFTR inhibitor did not affect the stimulation of the whole-cell current by LXA 4 in NuLi-1 cells ( Figure 5B ). When Nuli-1 cells were pre-treated with CFTR-inh172 (5 mM), subsequent LXA 4 exposure stimulated the outward and inward conductances by 2.160.15 fold and 2.560.14 fold (n = 3), respectively ( Figure 5B ). These results indicate that the stimulatory effect of LXA 4 on whole-cell current and conductance in non-CF and CF bronchial cells is mainly due to activation of NPPB-sensitive Cl 2 channels and does not involve CFTR channels.
LXA 4 Effects on Airway Surface Liquid Height
The consequence of LXA 4 stimulation of Cl 2 channels and transepithelial Cl 2 secretion on ASL height was investigated in the cell lines (Nuli-1, CuFi-1 and CuFi-3) and in primary cultures of non-CF and CF airway epithelial cells grown on permeable supports under an air/liquid interface. The ASL measurements were carried out after a period of 24 hours exposure to apical fluid (8 ml of PBS) to allow fluid absorption/secretion and ASL height to reach a steady state. Under control conditions (without LXA 4 ), the non-CF epithelia from NuLi-1 cell and primary cultures displayed a continuous unbroken ASL layer (not shown) whereas CF epithelia from cell lines and primary cultures presented a disrupted and thinner ASL layer (figure 6). Exposure to LXA 4 (100 nM, 15 min) increased the ASL height in both non-CF and CF cell lines and primary cultures (figure 6). LXA 4 treatment produced a maximum ASL height increase from 7.2560.07 mm (n = 6) to 9.960.1 mm (n = 6) in Nuli-1 epithelia (p,0.001) and from 4.660.20 mm (n = 6) to 11.160.20 mm (n = 6) in CuFi-1 epithelia (p,0.001), and from 6.460.1 mm (n = 6) to 9.560.2 mm (n = 6) in CuFi-3 epithelia (p,0.001) and from 4.960.32 mm (n = 9) to 9.860.10 mm (n = 9) in CFBE primary cultures (p,0.001). The ASL height response to LXA 4 obtained in CFBE primary cultures from 3 different CF patients was found to be robust and similar to the ASL response obtained in CuFi-1 differentiated cells. In all of the CF bronchial epithelia, the disrupted appearance of the ASL layer was absent following LXA 4 treatment (Figure 6 B, C, D).
Role of Cl
2 Transport in the ASL Height Responses to LXA 4 The Na/K/2Cl co-transporter inhibitor bumetanide was used to investigate the contribution of Cl 2 secretion to the generation of the ASL. Bumetanide (1 mM) treatment significantly decreased the basal ASL height (control 7.2560.07 mm, bumetanide 5.960.1 mm (p,0.001, n = 6)) in NuLi-1 monolayers but had no significant effect on ASL height in CuFi-1 epithelia (control 4.660.1 mm, bumetanide 4.8260.10 mm (p.0. 5, n = 6)), in CuFi-3 epithelia (control 6.460.1 mm, bumetanide 6.360.3 mm (p.0.5, n = 6)) and in CFBE (control 4.960.32 mm, bumetanide 
Role of the ALX/FPR2 Receptor in the ASL Height
Responses to LXA 4 We tested the effect of the ALX/FPR2 receptor antagonist Boc-2 on the ASL height response to LXA 4 . Boc-2 significantly reduced the effect of LXA 4 on ASL height in Nuli-1, CuFi-1 and CuFi-3 bronchial epithelial cell lines and CFBE primary cultures without affecting the basal ASL height ( Figure 6 ). These data support the conclusion that the LXA 4 as on calcium mobilization and Cl 2 secretion in bronchial epithelium.
Discussion
This is the first study to report a novel effect of the endogenous lipoxin LXA 4 to stimulate an increase in Airway Surface Liquid height, by enhancing Ca 2+ activated Cl 2 transport in bronchial epithelial cells obtained from patients with CF and non-CF patients and in airway cell lines.
In the healthy lung, the ASL forms a thin layer of fluid on the surface of the bronchial epithelium which allows cilia to beat effectively [8] . Maintenance of an optimal ASL height for ciliary beat is crucial for the efficacy of mucociliary clearance [8] [9] [10] [11] [12] . Bronchial epithelial ion transport regulates the ASL height, mainly by generating osmotic gradients which provide the driving force for transepithelial water movement [13] . In CF, the lack of functional CFTR leads to a reduced ASL height, resulting in an impaired mucociliary clearance that promotes chronic bacterial infection of the airways [3] . In a previous study, we reported that LXA 4 stimulated an intracellular Ca 2+ mobilization in a normal human airway epithelial cell line 16HBE14o- [7] . Here, we tested the hypothesis that LXA 4 induces a Ca 2+ signal to drive an increased Cl 2 secretion and ASL height in CF epithelium. Lipoxin A 4 thus stimulates a compensatory calcium-activated chloride secretory mechanism which overcomes the lack of CFTR mediated Cl 2 transport and enhances airway lumen hydration. Other studies have shown that LXA 4 exerts biological actions on human airway epithelial cells, with a maximal effect observed at 100 nM. LXA 4 (100 nM) inhibited IL-8 production by airway epithelial cells [14] , stimulated an intracellular Ca 2+ signaling [7] , increased Z0-1 expression and transepithelial electrical resistance [15] , and enhanced epithelial repair after an acid injury [16] . We report here, novel effects of LXA 4 on ion and fluid transport in normal and CF bronchial epithelia.
Our studies show that LXA 4 induces an intracellular Ca 2+ mobilization in normal and CF epithelia. The Ca 2+ response to LXA 4 involves signal transduction via the ALX/FPR2 receptor, since the FPR2 receptor antagonist Boc-2 inhibited the LXA 4 effect. This result supports our previous study which suggested that the Ca 2+ signal induced by LXA 4 was mediated by the ALX/ FPR2 receptor since the Ca 2+ response to LXA 4 was only obtained in the 16HBE14o-airway epithelial cell line that express the receptor whereas LXA 4 did not produce any Ca 2+ response in the A549 cell line which does not express ALX/FPR2 [7] .
Our results indicate that in non-CF airway epithelial cells, LXA 4 generates a rapid and transient calcium signal mainly arising from the release of Ca 2+ from intracellular stores and not as a result of increased Ca 2+ entry since the calcium signal was not affected by the removal of external Ca
2+
. This is in agreement with our previous findings showing that the Ca 2+ mobilization induced by LXA 4 was generated from thapsigargin sensitive stores [7] . In contrast, in CF airway epithelial cells, the duration of the Ca 2+ signal induced by LXA 4 was greater than in non-CF cells. Although, in CF cells, the removal of external calcium did not affect the maximum peak calcium increase, the calcium response to LXA 4 became more transient. These results suggest that, in CF airway epithelial cells, in addition to the calcium release from intracellular stores, LXA 4 also stimulates calcium entry which leads to an overall larger calcium mobilisation than in normal airway epithelial cells. The observed differences reported in the literature between the Ca 2+ signal obtained upon agonist exposure in CF and non-CF airway epithelial cells are controversial. Some authors reported that expression of either CFTR or DF508CFTR in airway epithelial cells had no effect on intracellular Ca 2+ [17] . However, our results are in accordance with the demonstration that Ca 2+ signaling is abnormal in CF airway epithelial cells and that correction of the abnormal trafficking of DF508CFTR protein restored intracellular Ca 2+ homeostasis [18] . Recent reports also indicate that intracellular Ca 2+ signals induced by pro-inflammatory mediators are increased in CF airway epithelia compared to non-CF due to an expansion of the apical endoplasmic reticulum Ca 2+ stores in CF airway epithelial cells [19] . This finding is consistent with several studies showing that the nasal transepithelial electrical potential responses to agents that promote an intracellular Ca 2+ mobilization and Ca 2+ -dependent Cl -conductance were higher in CF patients than in normal subjects [20] [21] [22] [23] .
Intracellular Ca 2+ regulates several epithelial functions including ion transport, mucin secretion, and ciliary beat frequency which constitute a primary mode of a non-specific cleansing process and lung protection. Our results indicate that the Ca 2+ signal induced by LXA 4 is coupled to an increased Cl 2 secretion in CF epithelium. LXA 4 stimulated the whole-cell current and conductance in non-CF and CF epithelial cells. The inhibitory effect of BAPTA-AM used as a chelator of intracellular Ca 2+ demonstrated the essential role of Ca 2+ in the stimulation of the whole-cell currents by LXA 4 . The sensitivity of basal and stimulated whole-cell currents to NPPB or Cl 2 substitution, underscores the major contribution of Cl 2 secretion to the generation of the whole-cell current. These results agree with our previous report indicating that LXA 4 stimulated a Ca 2+ -activated transepithelial Cl 2 secretion in non-CF bronchial epithelial cells [7] . Since we found that LXA 4 stimulation of the whole-cell currents was present in CF airway epithelia (in which CFTR is not functionally expressed), LXA 4 most probably affects Cl 2 channels other than CFTR. In addition, we found that the duration of the LXA 4 effect on whole-cell currents was different between non-CF and CF cells, with a transient current increase in non-CF cells compared to CF cells where the current increase was more sustained. One explanation may be that the time course of the effect of LXA 4 on the Cl 2 currents is directly related to the time course of the intracellular calcium change induced by LXA 4 . Therefore, the greater and sustained effect of LXA 4 on whole-cell currents in CF cells could be related to the long lasting Ca 2+ signal obtained in CF airway epithelial cells. Finally, the ineffectiveness of CFTR inh-172 on the LXA 4 stimulated whole-cell currents indicates that the effect of LXA 4 on Cl 2 secretion is not mediated by CFTR activation. This conclusion is strengthened by the observation that bumetanide reduces further the ASL height compared to Boc-2 treatment in Nuli-1 cells but not in CuFi-3 cells where functional CFTR is absent. If LXA 4 had stimulated CFTR and Ca 2+ -dependent Cl 2 channels together we would expect equivalent inhibition of ASL height by Boc-2 and bumetanide in Nuli-1 cells.
We have described a novel stimulatory effect of LXA 4 on Cl 2 secretion which produces an increased ASL height in both normal and CF epithelia. The CF bronchial epithelia generate a thinner ASL layer than non-CF airway epithelia. This finding is consistent with the diminished ASL in CF airways reported in the literature [12] . In addition, we observed that in control conditions, the non-CF epithelial monolayers showed a continuous ASL layer whereas in CuFi-1, CuFi-3 cell lines and CFBE primary cultures the liquid layer was disrupted. The gaps in the airway surface liquid layer result from localised de-hydration of the ASL. Following LXA 4 exposure in CF bronchial epithelia, the ASL height significantly increased and appeared uniform. The inhibitory effect of bumetanide indicates that the effect of LXA 4 on ASL height is mainly dependent on stimulation of transpithelial Cl 2 transport. However, we cannot exclude the possibility that LXA 4 can also exert its action to increase ASL height through the inhibition of ENaC activity which is known to be stimulated in CF airway and down-regulated by increased intracellular Ca
2+ . An important outcome of this work is the comparable results found for LXA 4 effects on ASL height in cell lines and primary CF cultures. We have demonstrated that using thin film airway liquid cell culture techniques, the NuLi and CuFi cell lines provide a robust model of airway liquid dynamics. Although ASL volume measurements have been published for the Calu-3 airway cell line [24] , it is important to distinguish between ASL volume and height measurements and their meaning for effective mucociliary clearance. ASL height is the relevant physiological parameter as it determines the effective beating of cilia which must be covered to an optimal height with ASL. The volume of ASL on the other hand may change without revealing the true optimal ASL height covering the cilia but instead may reflect flooding of the airways which would also render cilia beat inefficient for mucocilary clearance. Although the use of primary airway epithelia tissue is the ideal for research in CF, the access to patient tissue samples, particularly children with CF and 'normal' non-CF controls as in our study, is non-trivial. The use of particular airway cell lines such as NuLi and CuFi which in our hands display normal and CF airway epithelium phenotype to secrete a thin ASL and mucus provides an additional validated cell model for CF research where human tissue samples are rare and difficult to obtain for research purposes.
Taken together, our results provide evidence for a novel role of LXA 4 in stimulating Ca 2+ activated Cl 2 secretion and ASL generation in CF and non-CF airway epithelium. Thus LXA 4 or its stable analogues may provide a novel therapeutic strategy to rehydrate the CF airway by modulating ion transport and airway surface liquid height via pathways which bypass defective CFTR. Our findings also indicate that the reduced levels of LXA 4 observed in CF patients may be an additional contributory mechanism by which mucociliary clearance is diminished in CF airways.
Materials and Methods
Cell Culture
For the primary culture of human bronchial epithelium, the cells were obtained from bronchial brushing specimens obtained from 6 children (,6 years old) with CF and 5 non-CF controls through the SHIELD CF study (Study of Host Immunity and Early Lung Disease in CF). The children with CF were homozygous for the Phe508del mutation. Local ethics committee approval for the study was granted and written informed consent obtained. Bronchial epithelium brushings were washed and incubated for two hours at room temperature with 250 mg/ml amphotericin B in Phosphate Buffer Saline (PBS) without calcium and magnesium. After centrifugation, the pellet was collected and re-suspended in 500 ml of Bronchial Epithelium Basal Medium (BEBM, Clonetics, BioWhittaker, San Diego, USA) supplemented with 0.5 mg/ml human recombinant epidermal growth factor, 7.5 mg/ml bovine pituitary extract, 0.5 mg/ml epinephrine, 10 mg/ml transferrin, 5 mg/ml insulin, 0.1 mg/ml retinoic acid, 6.5 mg/ml triiodothyronine, and 50 mg/ml gentamicin (BD, Erembodegem, Belgium) and 250 mg/ml amphotericin B (BD, Erembodegem, Belgium). The explants were plated in a 24 well plate (Nunc, Roskilde, Denmark) previously coated with a fibronectin/collagen solution and incubated at 37uC in a humidified 5% CO 2 atmosphere. Twenty four hours after seeding, the volume of media was adjusted to 400 ml. The cells were cultured under these conditions for six to nine days (confluence close to 70%) before splitting. Fibroblasts were removed by 1 minute treatment with trypsin EDTA (Gibco, Invitrogen, Paisley, UK). Epithelial cells referred in this paper as NHBE (non-CF bronchial epithelial cells) and CFBE (CF bronchial epithelial cells) were then trypsinised and re-suspended after centrifugation, in supplemented BEBM. The cells were seeded at 2500-4000 cells/ cm 2 in flasks (BD, Erembodegem, Belgium).
NuLi-1, CuFi-1, CuFi-3, and CuFi-4 cells were kindly donated by Prof Zabner,University of Iowa, USA. The NuLi-1 cell line was derived from human airway epithelium of normal genotype, whereas CuFi-1, Cufi-3 and CuFi-4 cell lines were derived from CF patients with D508/D508, R553X/D508, and G551D/D508 genotypes respectively. The cell lines were transformed with a RT component of telomerase and human papillomavirus type 16 E6 and E7 genes [25] . Cells were initially grown to confluency in flasks using BEBM with EGF, hydrocortisone, bovine pituitary extract, transferin, bovine insulin, triiodothyronine, epinephrine, retinoic acid, penicillin-streptomycin (0.025 mg/ml), gentamicin (0.05 ng/ml), and amphotericin (25 mg/ml).
Airway epithelial cells were plated at 2610 6 cells/cm 2 on Millicell hanging cell culture inserts (Millipore, Billerica, USA) for ASL height measurements. All inserts were pre-coated with collagen type VI and grown in BEGM medium until confluence was achieved. Once cell confluence was confirmed under visual inspection, the medium was switched to DMEM/F-12 (Invitrogen, Auckland, New Zealand) to aid cell differentiation. This medium was supplemented with Ultroser G (2%, Pall Biospera, CergySaint-Christophe, France), which enhances ion transport [25] , and penicillin-streptomycin (0.025 mg/ml), gentamicin (0.05 ng/ml), and amphotericin (25 mg/ml). Medium at the apical aspect was aspirated every 3-4 days until the establishment of an air-liquid interface. The basolateral culture medium was replaced every 2-3 days. After 4-6 weeks growth, the cells formed a polarised confluent monolayer with a high transepithelial electrical resistance (TER) of .700 V/cm 2 .
Intracellular Calcium Imaging
Intracellular Ca 2+ was measured by epifluorescence microscopy as previously described [26] . The human airway epithelial cells were cultured on fibronectin-collagen coated (for primary culture cells) and on collagen VI coated (for NuLi-1 and CuFi-1 cells) glass bottom dishes (WPI, Stevenage, UK) for 6 days until 70% of confluence was reached. Cells were loaded with 5 mM of the Ca 2+ -sensitive fluorescent probe fura-2-acetoxy-methyl ester (fura 2-AM, Invitrogen, Auckland, New Zealand) for 30 min, in the dark, at room temperature (22uC) and were then washed twice in HEPES-buffered Krebs-Henseleit solution (140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl 2 , 10 mM HEPES, pH 7.4, 280-290 mOsmol). The glass bottom dishes covered with the fura 2-AM loaded epithelial cell monolayer were mounted on the stage of an inverted microscope equipped for epi-fluorescence (TE-300, Nikon, Badhoeve Dorp, Netherlands). Intracellular Ca 2+ imaging was performed using the Metafluor Imaging System (Universal Imaging Corporation). The cell preparation was excited alternatively with monochromatic light at 340 and 380 nm using an Optoscan monochromator (Cairn Research Ltd, Kent, UK). The emission fluorescence produced after fura 2-AM excitation was filtered at 512 nm. The emitted light image was detected using a Photometrics CoolSNAP-fx video camera (Roper Scientific, Evry, France) coupled to the microscope. The fluorescence obtained at each excitation wavelength (F340 and F380) depended upon the level of Ca 2+ binding to fura 2-AM. The results are given as ratiometric data (F340/F380), or as amplitude of variation compared to the basal ratio level (DF340/F380).
Whole-cell Patch-clamp Recording
Freshly isolated epithelial cells obtained from 4 non-CF patients and from 3 CF patients (genotype: DF508/DF508) and from the NuLi-1 and CuFi-3 cell lines were used for patch-clamp experiments. The CuFi-1 cells were not used for patch-clamp experiments since we could not reach a Giga ohm seal with these cells. Cells were patch-clamped at room temperature (25uC) on an inverted microscope (TE-300, Nikon, Badhoeve Dorp, Netherlands). Patch-pipettes were prepared from soda glass (Vitrex, Modulhom, Herlev, Denmark), pulled on a programmable puller (P80/PC, Sutter Instrument Company, USA). The whole-cell configuration was obtained from cell-attached mode after breaking the patch membrane by applying a brief negative pressure in the patch pipette. Whole-cell currents were amplified (Axopatch 200B, Axon instrument, CA) and digitized using a 16-bit data converter (Digidata 1322A, Axon instrument, CA) following low pass filtering at 5 Khz and sampled in real-time. Whole-cell current voltage (IV) relationships were analysed using Clampfit software (Axon instrument, CA).
The were 277 mV and 239 mV, respectively. The access resistance (Ra) was determined by fitting the current transients produced by a 5mV voltage pulse with a single exponential. The measured Ra was 5.4360.08V (n = 40). For experiments performed in ''low internal calcium'', cells were bathed in Kreb's solution and the patch pipette contained 100 nM CaCl 2 with 5 mM EGTA and 10 mM BAPTA-AM. In these conditions the free Ca 2+ has been estimated at 1 pM using the free software WEBMAXC http://www.stanford.edu/cpatton/ webmaxc/webmaxcS.htm.
Airway Surface Liquid (ASL) Height Measurements
ASL height was measured using a protocol adapted from Tarran et al. (10) , using live-cell confocal fluorescence microscopy. To label the ASL, 8 ml PBS containing 1 mg/ml Texas redHdextran (10 kD; Invitrogen, Auckland, New Zealand) was added to the apical surface of the well-differentiated airway epithelium. The epithelial cells were stained using Calcein-AM (5 mM, Invitrogen, Auckland, New Zealand) dissolved in medium culture for 30 minutes and introduced to the basolateral compartment of the insert. The Fluorinet TM electronic fluid Perfluorocarbon-72 (FC-72, 3M, St Paul, USA) was added to the apical compartment of the insert at a volume of 0.5 ml. Perfluorocarbon-72 is immiscible with the ASL and was used to prevent ASL evaporation on transferring the inserts from the incubator to the microscope stage and during the confocal scanning experiments. Epithelia were Z-scanned using a Zeiss LSM 510 Meta using a 40X objective. For each culture insert, 3 different microscope fields randomly chosen were XZ scanned. In each microscope field, the ASL height was measured using the Zeiss LSM Image analyser software (Carl Zeiss Microlmaging GmbH, Germany) in 9 separate regions randomly determined and then averaged. This method of quantification was carried out after blind analysis performed by multiple users. The n values referred to the number of culture inserts tested in a given condition.
Drugs
The lipoxin LXA 4 was purchased from Calbiochem. Aliquots of LXA 4 solution (100 mM) in ethanol were stored at 280uC to avoid degradation of the molecule. The peptide Boc-Phe-Leu-Phe-LeuPhe (Boc-2) (Phoenyx pharmaceutical, Belmont, USA) was used as specific inhibitor of the ALX/FPR2 receptor (11) . For these latter experiments, cells were pre-incubated with 10 25 M Boc-2 for 24 hours at 37uC. BAPTA-AM (10 mM, Molecular probes, Leiden, Netherlands) was used to chelate intracellular Ca 2+ (12) . The 5-Nitro-2-(3-phenylpropylamino) benzoic acid (NPPB, Sigma, USA) used at 1 mM is an inhibitor of Ca 2+ -activated Cl 2 channels (13). CFTRinh-172 an antagonist of the CFTR channel and bumetanide an inhibitor of the NKCC1 co-transporter were supplied by Sigma (14) .
Data Analysis
The intracellular Ca 2+ variations were measured as the difference between the mean F340/F380 ratio during the 2 min prior to exposure to LXA 4 and the ratio measured at the peak of the Ca 2+ response and 2 and 5 min after the peak. In each experiment, the mean ratio was obtained from all cells in the microscopic field. In whole-cell patch-clamp experiments, conductances were determined by linear regression of the currentvoltage relationship obtained in n cells. For the ASL height measurements, three confocal image acquisitions were performed on each culture insert and nine regions of interest were analysed in the acquisition field using the LSM image browser (Zeiss). Values were loaded in an Excel spreadsheet and averaged. Mean value were obtained from n independent experiments. The experiments were repeated under the same conditions on a minimum of three different cell passages. Data are presented as the mean 6 S.E.M. of n experiments. Measures of statistical significance were obtained using the Student's t test for paired data. A p value ,0.05 was deemed to be significant. All statistical operations were performed using Excel software (Microsoft).
